According to the analysis of related databases, 24134-09-6, the application of this compound in the production field has become more and more popular.
Each compound has different characteristics, and only by selecting the characteristics of the compound suitable for a specific situation can the compound be applied on a large scale. 24134-09-6, name is 5-Bromo-1,2-dimethyl-1H-imidazole, This compound has unique chemical properties. The synthetic route is as follows., Computed Properties of C5H7BrN2
A solution of 5-bromo-1,2-dimethyl- 1H-imidazole (10.6 g, 60.8 mmol) in THF (400 mE) was cooled to -77 C. Maintaining a temperature of<-70 C., nBuLi (27.7 ml, 72.0 mmol, 2.5 M in hexanes) was added over 10 mm. After 10 mm, a solution of (4-chloro-2-methoxy-3-(4-(trifluorom- ethyl)benzyl)quinolin-6-yl)(1 -methyl-i H-i ,2,3-triazol-5-yl)methanone (20.0 g, 43.4 mmol, Intermediate 63) inTHF (290 mE) was added over 10 mm maintaining a temperature of <-60 C. The reaction mixture was allowed to warm to 0 C. over 1 hand then quenched with aqueous ammonium chloride (500 mE, 13 wt %). The resulting layers were separated and the organic layer was washed with brine (400 mE). The organic layer was dried over Mg504, filtered, and concentrated. The residue was taken up in acetone (200 mE) and allowed to stir for 2 h. The resulting suspension was filtered and washed with acetone (20 mE). After drying in a vacuum oven at 60 C. the title compound was obtained as a white solid. ?H NMR (400 MHz, CDC13) oe ppm 8.24 (d, J=2.2 Hz, iH), 7.72 (d, J=8.7 Hz, iH), 7.54-7.47 (m, 3H), 7.42-7.33 (m, 3H), 7.06 (s, iH), 5.97 (s, iH), 4.32-4.22 (m, 2H), 4.06 (s, 3H), 3.88 (s, 3H), 3.32 (s, 3H), 2.13 (s, 3H); MS mle 557.1 (M+H). (4-chloro-2-methoxy-3-(4-(trifluoromethyl)benzyl) quinolin-6-yl)(i ,2-dimethyl- 1 H-imidazol-5-yl)(i -methyliH-i,2,3-triazol-5-yl)methanol was resolved into its constituent enantiomers by chiral HPEC [Chiralcel OD, mobile phase: 85% heptane, 15% ethanol]. Afier resolution, the individual enantiomers were crystallized from acetone (7.5 mE/g) and isolated by filtration after the addition of heptane (15 mE/g). The first eluting enantiomer was Example 80B: ?H NMR (400 MHz, CDC13) oe ppm 8.23 (d, J=2.2 Hz, iH), 7.72 (d, J=8.8 Hz, iH), 7.51 (d, J=8.2 Hz, 2H), 7.43-7.33 (m, 3H), 7.05 (s, iH), 6.99 (bs, iH), 6.01 (s, iH), 4.30 (s, 2H), 4.06 (s, 3H), 3.88 (s, 3H), 3.34 (s, 3H), 2.17 (s, 3H); MS mle 557.1 (M+H). The second eluting enantiomer was Example 80C:?H NMR (500 MHz, CDC13) oe ppm 8.19 (d, J=2.2 Hz, iH), 7.74 (d, J=8.7 Hz, iH), 7.52 (d, J=8.2 Hz, 2H), 7.43-7.35 (m, 3H), 7.14 (s, iH), 6.08 (s, iH), 5.32 (bs, iH), 4.33 (s, 2H),4.07 (s, 3H), 3.91 (s, 3H), 3.38 (s, 3H), 2.28 (s, 3H); MS mle557.1 (M+H).
According to the analysis of related databases, 24134-09-6, the application of this compound in the production field has become more and more popular.
Reference:
Patent; Janssen Pharmaceutica NV; Leonard, Kristi A.; Barbay, Kent; Edwards, James P.; Kreutter, Kevin D.; Kummer, David A.; Maharoof, Umar; Nishimura, Rachel; Urbanski, Maud; Venkatesan, Hariharan; Wang, Aihua; Wolin, Ronald L.; Woods, Craig R.; Pierce, Joan; Goldberg, Steven; Fourie, Anne; Xue, Xiaohua; US2014/107094; (2014); A1;,
Imidazole – Wikipedia,
Imidazole | C3H4N2 – PubChem